Medicare coverage for anti-rejection meds would be extended under House bill

08/7/2013 | Oregonian (Portland), The

A House measure sponsored by Rep. Mike Burgess, R-Texas, would make permanent Medicare's coverage of anti-rejection drugs for kidney transplant patients. Medicare currently covers only three years' worth of the drugs, which are needed for life. The cost of approximately 10 more years of immunosuppressive treatments would be $150,000, but that would be cost-effective compared with a lifetime of dialysis treatments, according to an official with Legacy Transplant Services in Portland, Ore.

View Full Article in:

Oregonian (Portland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX